Efficacy and safety of glargine insulin injection Uslen versus Lantus in diabetic patients: a multicenter, randomized, open-labeled controlled trial

医学 糖化血红素 甘精胰岛素 内科学 随机对照试验 糖尿病 不利影响 胰岛素 胃肠病学 低血糖 2型糖尿病 内分泌学
作者
Yunhui Liu,Li-qiong Hou,Tie-yun Zhao,Haoming Tian,Xiaofeng Lyu,Jinkui Yang,Ling Li,Lyuyun Zhu,Lihui Zhang,Changjiang Wang,Shandong Ye,Zhiguang Zhou,Zhaohui Mo,Xiaoyue Wang,Zhongyuan Wen,Yaoming Xue,Pan Hai-lin,Xiaodong Yan,Mian Xu,Ganxiong Liang,Jianhua Ma,Guangyao Song
出处
期刊:Chin J Diabetes Mellitus 卷期号:6 (6): 377-381
标识
DOI:10.3760/cma.j.issn.1674-5809.2014.06.006
摘要

Objective To evaluate the efficacy and safety of glargine insulin injection (Uslen) in treatment of diabetic patients. Methods A multicenter, randomized, open-labeled and positive control clinical trial included the patients with type 1 or type 2 diabetes mellitus having poor glucose control after using oral antidiabetic drug or short-acting insulin. All patients were treated with Uslen or Lantus for 16 weeks in two groups by a ratio of 1∶1. The decreased value and qualification rates of glycated hemoglobin A1c(HbA1c) and fasting blood glucose (FBG), the incidence of hypoglycemic and the adverse events were compared pretreatment at the end of 16 weeks' treatment. Results All of 664 cases were randomized into two groups and received therapy (1∶1). But 623 cases were in complete conformity to design plan, 313 cases received Uslen therapy and 310 cases received Lantus therapy. There were no different in age, sex, nation, height and weight between two groups. At the end of 16 weeks' treatment, according to the per-protocol analysis (PPS), the decreased values of HbA1c separately (9.2±1.5)% vs (7.7±1.2)% and (9.3±1.5) vs (7.7±1.1)%, FBG separately (10.2±2.1 vs 7.2±2.0) mmol/L and (10.3±2.3 vs 7.4±2.3) mmol/L were all proved significantly in both Uslen group and Lantus group (all P 0.05). There were no significant difference in the two groups on the qualification rates of HbA1c(26.2%(82/313)vs 21.3%(66/310), P=0.155) and FBG(29.1%(91/313) vs 28.4%(88/310), P>0.05). There were no significant difference separately 22.7% (75/330) and 22.0% (74/333) on hypoglycemia incidences, and the other adverse events incidences were similar separately 0.3% (1/330 vs 1/333, P>0.05) in two groups. Conclusion Compared with Lantus, the glargine insulin injection of Uslen has similar effect on lowering blood sugar and good security, which has better clinical value. Key words: Diabetes mellitus; Insulin, glargine; Efficacy; Safety

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
小明同学完成签到 ,获得积分10
2秒前
2秒前
1sss完成签到,获得积分10
3秒前
3秒前
传奇3的应助被zhaoxiao采纳,获得10
3秒前
心灵美的幼蓉完成签到,获得积分10
3秒前
11完成签到 ,获得积分10
3秒前
辞旧完成签到,获得积分10
3秒前
4秒前
yjj发布了新的文献求助10
5秒前
坚定夜蕾完成签到,获得积分10
5秒前
Alphaz9918完成签到,获得积分10
5秒前
5秒前
假装忧郁被发现完成签到 ,获得积分10
5秒前
6秒前
zetero发布了新的文献求助10
6秒前
毕竟话少完成签到,获得积分10
7秒前
鲤鱼盼夏发布了新的文献求助10
7秒前
彭于晏的应助被零一采纳,获得10
8秒前
9秒前
9秒前
Hello的应助被cd采纳,获得10
9秒前
9秒前
penghui发布了新的文献求助10
10秒前
Wendy完成签到,获得积分10
10秒前
er发布了新的文献求助10
11秒前
SciGPT的应助被Summer夏天采纳,获得10
12秒前
12秒前
活泼的煎饼完成签到,获得积分10
12秒前
DOC_XIONG的应助被lc采纳,获得10
12秒前
清白之年的应助被lc采纳,获得10
13秒前
秒速五厘米的应助被lc采纳,获得10
13秒前
秒速五厘米的应助被lc采纳,获得10
13秒前
13秒前
Yyy完成签到 ,获得积分10
13秒前
14秒前
14秒前
zhaoxiao发布了新的文献求助10
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161158
求助须知:如何正确求助?哪些是违规求助? 9555911
关于积分的说明 21731165
捐赠科研通 7751082
什么是DOI,文献DOI怎么找? 3427515
关于科研通互助平台的介绍 2552547
邀请新用户注册赠送积分活动 2471950